Estrogen-induced improvement in coronary flow responses during atrial pacing in relation to endothelin-1 levels in postmenopausal women without coronary disease

Vascular Health and Risk Management

Volumn 4, Issue 3, 2008, Pages 705-714

  Kallikazaros, Ioannis ^a   Tsioufis, Costas ^a   Zambaras, Panagiotis ^a   Skiadas, Ioannis ^a,b   Toutouza, Marina ^a   Tousoulis, Dimitrios ^a   Stefanadis, Christodoulos ^a   Toutouzas, Pavlos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Coronary blood flow; Coronary interventions; Endothelin 1; Estrogens

Indexed keywords

ENDOTHELIN 1; ESTRADIOL; SODIUM CHLORIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY SINUS; CORRELATION FUNCTION; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; HEART ATRIUM PACING; HEART PROTECTION; HUMAN; MENOPAUSAL SYNDROME; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

CARDIAC PACING, ARTIFICIAL; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTMENOPAUSE;

EID: 47849096592     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Alexander KP, Newby LK, Hellkamp AS, et al. 2001. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. JACC, 38:1-7.
2. Austin C. 2000. Chronic and acute effects of estrogens on vascular contractility. J Hypertens, 18:1365-78.
3. Best PJM, Berger PB, Miller VM, et al. 1998. The effect of estrogen replacement on plasma nitric oxide and endothelin-1 levels in post-menopausal women. Ann Intern Med, 128:285-8.
4. Collins P, Rosano GMC, Sarrel PM, et al. 1995. Estradiol-17β attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation, 92:24-30.
5. Gilligan DM, Quyyumi AA, Cannon RO. 1994. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation, 89:2545-51.
6. Grady D, Hulley SB. 2001. Postmenopausal hormones and heart disease. JACC, 38:8-10.
7. Grodstein F, Manson JE, Colditz GA, et al. 2000. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med, 133:933-41.
8. Gueta V, Quyyumi A, Prasan D, et al. 1997. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation, 96:2795-801.
9. Herrington DM, Reboussin DM, Brosnihan KB, et al. 2000. Effects of estrogen on the progression of coronary artery atherosclerosis. N Engl J Med, 343:522-9.
10. Hsia J, Simon J, Lin F, et al. 2000. Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary artery disease. The Heart and Progestin Replacement Study. Circulation, 102:2228-32.
11. Hulley S, Grady D, Bush T, et al. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women: Heart and Estrogen/progestin Replacement Study (HERS) research group. JAMA, 280:605-13.
12. Jhund P, Dawson N, Davie A, et al. 2001. Attenuation of endotheline-1 induced vasoconstriction by 17β-estradiol is not sustained during long term therapy in postmenopausal women with coronary artery disease. JACC, 37:1367-73.
13. Jiang C, Sarrel PM, Poole-Wilson PA, et al. 1992. Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol, 263:H271-5.
14. Kallikazaros I, Tsioufis C, Zambaras P, et al. 2002. Conjugated estrogen administration improves common carotid artery elastic properties in normotensive postmenopausal women. Clin Cardiol, 25:167-73.
15. Lamping KG, Nuno DW. 1996. Effects of 17 beta-estradiol on coronary microvascular responses to endothelin-1. Am J Physiol, 271: H1117-24.
16. Lerman A, Holmes DRJ, Bell MR, et al. 1995. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation, 92:2426-31.
17. Lieberman EH, Gerhard MD, Uehata A, et al. 1994. Estrogen improves endothelium-dependent flow-mediated vasodilation in postmenopausal women. Ann Intern Med, 121:936-41.
18. Nishikawa Y, Ogawa S. 1997. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. JACC, 29:85-92.
19. Polderman K, Stehouwer C, Van Kamp G, et al. 1993. Influence of sex hormones on plasma endotheline levels. Ann Inter Med, 118:429-32.
20. Quyyumi A, Dakak N, Andrews N, et al. 1995. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation, 92:320-6.
21. Reis SE, Gloth ST, Blumenthal RS, et al. 1994. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation, 89:52-60.
22. Rosano G, Caixeta AM, Chierchia S, et al. 1997. Short-tem anti-ischemic effect of 17β-estradiol in postmenopausal women with coronary artery disease. Circulation, 96:2837-41.
23. Rosano G, Sarrel PM, Poole-Wilson PA, et al. 1993. Beneficial effect of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet, 342:133-6.
24. Stampfer MJ, Colditz GA, Willett WC, et al. 1991. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses health study. N Engl J Med, 325:756-62.
25. Sudhir K, Jennings GL, Funder JW, et al. 1996. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension, 28:3330-4.
26. Sudhir K, Ko E, Zellner C, et al. 1997. Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. Circulation, 96:3626-32.
27. Vojacek J, Rohac J, Kirkeelde R, et al. 1995. Changes in proximal and distal coronary artery diameter during atrial pacing-induced myocardial ischemia. Coron Artery Dis, 6:685-91.
28. Webb C, Ghatel M, McNeill J, et al. 2000. 17β-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation, 102:1617-22.